Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216963 · ClinicalTrials.gov registry record · NA
The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study
A NA study, sponsored by Duke University.
- Not yet
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT07216963: Clinical Trial NA study, sponsored by Duke University.
NCT07216963 is a NA study that has not yet begun recruiting, run by Duke University. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07216963, a NA study, has not yet begun recruiting, sponsored by Duke University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to develop and test the CROSSROADS intervention. CROSSROADS is designed for people who have recently survived an opioid and/or stimulant-related non-fatal overdose and had contact with staff from a Community Paramedic (CP) program. Participants will be randomly placed into one of two groups: 1\) Standard of care from the CP program, or 2) CROSSROADS, which includes CP care plus a Medical-Legal Partnership (MLP). The MLP helps people with legal problems that can affect their health-- like issues with housing or public benefits. Researchers will test if the CROSSROADS intervention reduces drug use and involvement with the criminal legal system. People in the study will be followed for one year and asked to complete surveys at the beginning, and again at 1 month, 6 months, and 12 months.
Primary Outcome
As measured by the number of days of use per month per participant.
Interventions
- BEHAVIORAL Community Paramedic Standard of Care (CP SOC)
- BEHAVIORAL CROSSROADS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2030-08-01 |
| Phase | NA |
What is known before NCT07216963 opens enrollment
NCT07216963 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 2 interventions - of which Community Paramedic Standard of Care (CP SOC) is the first listed.
NCT07216963 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07216963 about?
NCT07216963 is a clinical study titled "The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study". The goal of this clinical trial is to develop and test the CROSSROADS intervention. CROSSROADS is designed for people who have recently survived an opioid and/or stimulant-related non-fatal overdose and had contact with staff from a Community Paramedic (CP) program. Participants will be randomly pl...
What is the current status of trial NCT07216963?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2026-09-01. Estimated completion is 2030-08-01.
What interventions are being tested in trial NCT07216963?
The interventions under investigation include: Community Paramedic Standard of Care (CP SOC) (BEHAVIORAL), CROSSROADS (BEHAVIORAL).
Who is sponsoring clinical trial NCT07216963?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07216963's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI